On Tuesday, Bernie Sanders’ Twitter account sent out a series of tweets describing the price hike on insulin from pharmaceutical company Eli Lilly and Co. The tweets linked to a Washington Post article that details the increasing prices from the day insulin was discovered in 1921 until today. Sanders’ tweets attacked the drug industry, accusing the companies involved of corporate greed.

A bit of backstory is necessary: the researchers who discovered insulin debated whether to patent it at all since their main purpose was to help humanity. Their discovery made it possible for people to live with a disease that had previously meant a death sentence. Eventually they sold the patent for $3 to the University of Toronto.

Why has the price of Humalog insulin gone up 700% in 20 years? It’s simple. The drug industry’s greed. pic.twitter.com/SUeSbsr2Ka

— Bernie Sanders (@SenSanders) November 1, 2016

Sanders’ tweets, which were not signed by him personally but sent out by staff members, caused Eli Lilly’s stock price to drop 2.4 percent. The price of $72.02 per share was the lowest it has been since March 31. Prices soon stabilized again, and Eli Lilly released a statement defending its pricing.

“A permanent solution that gives everyone who uses insulin reasonable access will require leadership and cooperation across many stakeholders, including manufacturers, (pharmacy benefit managers), payers, and policymakers. That’s because the answer itself isn’t simple.”

Eli Lilly and Novo Nordisk clearly care more about their profits than their patients. It’s time to end their greed. pic.twitter.com/MqCsHNjzcO

— Bernie Sanders (@SenSanders) November 1, 2016

This year marks 75 years after the original patent on insulin expired and three companies in particular have made improvements to insulin that leads to the creation of more patents and garnered the owners billions of dollars. One of those companies is Eli Lilly; its insulin Humalog has gone up in price from $21 in 1996 to $255 today. That’s a 700 percent increase.

But why isn’t competition keeping the prices down? The pharmaceutical industry claims drug improvement raises prices, but experts question this and believe the changes to the drugs are only to cover up for price hikes as well as to create new patents. David Nathan from Harvard Medical School said to the Post:

I don’t think it takes a cynic such as myself to see most of these drugs are being developed to preserve patent protection. The truth is they are marginally different, and the clinical benefits of them over the older drugs have been zero.

Many people can’t even afford to get their insulin. Around six million Americans depend on it, and though many get it through health insurance, there are also many without insurance or in between insurance plans because of different life changes.

In the richest nation in the world, diabetes patients are being forced to decide between eating and paying for the drugs they need. pic.twitter.com/Mnq4NSgiPz

— Bernie Sanders (@SenSanders) November 1, 2016

Sanders has targeted the drug industry before and influenced the stock market through his tweets about Ariad Pharmaceuticals’ high prices for a leukemia drug. Hillary Clinton is doing pretty well too–she has tweeted both at the industry in general, causing Nasdaq shares to fall last year, and about the EpiPen by Mylan NV, whose shares fell by 6.2 percent. If these progressive politicians keep it up, maybe things will change after all!

Emma Von Zeipel

Emma Von Zeipel is a staff writer at Law Street Media. She is originally from one of the islands of Stockholm, Sweden. After working for Democratic Voice of Burma in Thailand, she ended up in New York City. She has a BA in journalism from Stockholm University and is passionate about human rights, good books, horses, and European chocolate. Contact Emma at EVonZeipel@LawStreetMedia.com.

The post Insulin Brand’s Stock Plummets After Bernie Sanders Tweets About Price Hikes appeared first on Law Street.

Wells Fargo, America’s biggest bank by market capitalization, has apparently been scamming its customers by opening unauthorized deposit and credit card accounts for years. High sales targets and promises of bonuses prompted employees to commit illegal cross-selling–which is when you sell multiple products or services to the same customers. In fact, 5,300 employees have been fired for “inappropriate sales conduct” over the past five years.

On Thursday the Consumer Financial Protection Bureau (CFPB) fined the bank $100 million, which is the highest fine the federal agency has ever issued. Additional fines of $35 million and $50 million each are to be paid to the Office of the Comptroller of the Currency, and to the City and County of Los Angeles.

The director at CFPB, Richard Cordray, said in a press release:

Wells Fargo employees secretly opened unauthorized accounts to hit sales targets and receive bonuses. Because of the severity of these violations, Wells Fargo is paying the largest penalty the CFPB has ever imposed. Today’s action should serve notice to the entire industry that financial incentive programs, if not monitored carefully, carry serious risks that can have serious legal consequences.

Banking analyst Dick Bove said on Friday that it’s time to sell your stocks in the bank. He told CNBC: “What Wells has done is it’s saying that it’s treating customers badly, it broke faith with customers. There is no business in the world that can treat its customers badly and continue to expect to grow.”

To gain back the public’s trust after something big like this, especially with the 2008 financial crisis fresh in mind, Bove said Wells Fargo would need to do something drastic. For example, forgive all student loan debt. He said:

If you do that to customers who have student loans, they’ll stay with you for life. It requires something big, comprehensive and meaningful. Whether it’s that exact action or some other action that they come up with, I don’t know. I think it requires a significant step to re-establish faith with the consumer.

Many Twitter users reacted to the news.

“Hello Wells Fargo, I’d like to open a checking account, savings account and two credit cards.”
“You’re in luck. We’ve already opened them.”

— Fake Dispatch (@Fake_Dispatch) September 9, 2016

And one popular question is why no higher executives have been held accountable.

It’s weird how 5,000 front line Wells Fargo employees hit on similar scams without any wrongdoing by high-level executives.

— Matthew Yglesias (@mattyglesias) September 9, 2016

Essentially, employees at the bank boosted their sales by secretly opening new accounts and then funding them by transferring money from customers’ existing accounts. This often brought along additional fees and charges for the customers. It’s been reported that more than two million deposit or credit accounts were opened in this fashion. According to Reuters, employees were told that most customers used six financial tools but that they should push them into using at least eight.

According to CNN’s Douglas Rushkoff, the scale of these scams show that it’s not just the behavior of one bad banker, but rather a symptom of extreme capitalism in the banking world. Since banks make money from extracting funds from customers who want to invest or make transactions, they need to make sure those processes happen. During a time with slow growth though, the bankers need to create some kind of growth synthetically, out of fear of losing their jobs or missing out on a bonus. An easy way to do this is extract more money from people who already are customers, by offering new credit cards with higher fees or loans with higher costs or new terms that are worse for the customer but better for the bank.

Wells Fargo has been known for its ability to cross-sell multiple products to the same customers. In a statement on the bank’s website it said:

Wells Fargo is committed to putting our customers’ interests first 100 percent of the time, and we regret and take responsibility for any instances where customers may have received a product that they did not request.

Wells Fargo has issued a statement regarding definitive settlement agreements. Read more: https://t.co/tCMOlGkfln. pic.twitter.com/DSEjFC1BpA

— Wells Fargo News (@WellsFargoNews) September 8, 2016

Emma Von Zeipel

Emma Von Zeipel is a staff writer at Law Street Media. She is originally from one of the islands of Stockholm, Sweden. After working for Democratic Voice of Burma in Thailand, she ended up in New York City. She has a BA in journalism from Stockholm University and is passionate about human rights, good books, horses, and European chocolate. Contact Emma at EVonZeipel@LawStreetMedia.com.

The post How Will Wells Fargo Recover From its Fraud Scandal? appeared first on Law Street.